Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential

scientific article published on 20 March 2007

Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/MT.SJ.6300131
P698PubMed publication ID17375072
P5875ResearchGate publication ID6432498

P2093author name stringYu-Chen Hu
Yiu-Kay Lai
Hung-Jen Liu
Yao-Chi Chung
Chia-Wei Lai
Ding-Gang Yang
P2860cites workTruncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivoQ45422816
Baculovirus as a highly efficient gene delivery vector for the expression of hepatitis delta virus antigens in mammalian cellsQ45532831
Determination of the baculovirus transducing titer in mammalian cellsQ45888110
Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune responseQ47773636
Baculovirus-mediated gene expression in chicken primary cells.Q50733500
Characterization of cell-surface determinants important for baculovirus infection.Q52585258
Altering the surface properties of baculovirus Autographa californica NPV by insertional mutagenesis of the envelope protein gp64.Q52599079
Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccineQ73593910
Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenzaQ80422025
Baculovirus entry into human hepatoma cellsQ24534731
Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusionQ27863777
Site-specific mutagenesis identifies three cysteine residues in the cytoplasmic tail as acylation sites of influenza virus hemagglutininQ28646303
Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.Q30322954
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.Q30327772
Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.Q30341146
Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.Q30351356
Baculoviral display of the green fluorescent protein and rubella virus envelope proteins.Q30428621
Non-polar distribution of green fluorescent protein on the surface of Autographa californica nucleopolyhedrovirus using a heterologous membrane anchorQ31055145
Amino-terminal anchored surface display in insect cells and budded baculovirus using the amino-terminal end of neuraminidaseQ31118368
Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface.Q32060361
Recombinant baculoviruses as expression vectors for insect and mammalian cellsQ33744882
Influenza virus geneticsQ33953751
Baculovirus as versatile vectors for protein expression in insect and mammalian cellsQ34416430
The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteinsQ34553841
Budding of rabies virus particles in the absence of the spike glycoproteinQ34662773
Location, sequence, transcriptional mapping, and temporal expression of the gp64 envelope glycoprotein gene of the Orgyia pseudotsugata multicapsid nuclear polyhedrosis virusQ35845998
Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.Q35887822
Baculovirus as a highly efficient expression vector in insect and mammalian cells.Q36075878
Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domainQ36626279
Baculovirus vectors elicit antigen-specific immune responses in miceQ36684637
Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment)Q37590682
Baculovirus surface display: construction and screening of a eukaryotic epitope libraryQ38337245
Palmitoylation of the Autographa californica multicapsid nucleopolyhedrovirus envelope glycoprotein GP64: mapping, functional studies, and lipid raftsQ39752634
The GP64 envelope fusion protein is an essential baculovirus protein required for cell-to-cell transmission of infectionQ39875210
Dual expression of the HA protein of H5N2 avian influenza virus in a baculovirus systemQ40306206
Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entryQ40329154
Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infectionQ40619739
Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: focuses on strategic infection and feedingQ40658538
Influenza viruses select ordered lipid domains during budding from the plasma membraneQ40980312
Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virusQ41051042
Immunological properties of FMDV-gP64 fusion proteins expressed on SF9 cell and baculovirus surfaces.Q42043174
Baculoviral display of functional scFv and synthetic IgG-binding domains.Q42055956
Requirement for GP64 to drive efficient budding of Autographa californica multicapsid nucleopolyhedrovirusQ42059198
Ligand-directed gene targeting to mammalian cells by pseudotype baculovirusesQ42716737
P433issue5
P921main subjectavian influenzaQ43987
P1104number of pages8
P304page(s)989-996
P577publication date2007-03-20
P1433published inMolecular TherapyQ15762400
P1476titleAvian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential
P478volume15

Reverse relations

cites work (P2860)
Q35061504A baculovirus dual expression system-based vaccine confers complete protection against lethal challenge with H9N2 avian influenza virus in mice
Q39096206A novel baculovirus vector shows efficient gene delivery of modified porcine reproductive and respiratory syndrome virus antigens and elicits specific immune response.
Q59359064A secretary bi-cistronic baculovirus expression system with improved production of the HA1 protein of H6 influenza virus in insect cells and Spodoptera litura larvae
Q42268317Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease
Q30386196Baculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in Mice
Q56514706Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development
Q37873083Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications
Q45869596Baculovirus as a new gene delivery vector for stem cell engineering and bone tissue engineering
Q36337148Baculovirus as a vaccine vector
Q39649585Baculovirus as an avian influenza vaccine vector: Differential immune responses elicited by different vector forms
Q43001874Baculovirus surface display of E envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models
Q39949984Baculovirus surface display of E2 envelope glycoprotein of classical swine fever virus and immunogenicity of the displayed proteins in a mouse model
Q39937129Baculovirus surface display of sigmaC and sigmaB proteins of avian reovirus and immunogenicity of the displayed proteins in a mouse model
Q91783230Baculovirus surface display of the HA protein of H5N2 avian influenza virus and its immunogenicity against a lethal challenge with H5N1 virus in chickens
Q37434539Baculovirus vector as a delivery vehicle for influenza vaccines
Q57064366Baculovirus vector for gene delivery and vaccine development
Q40880160Baculovirus vectors expressing F proteins in combination with virus-induced signaling adaptor (VISA) molecules confer protection against respiratory syncytial virus infection
Q35897609Baculovirus-based Vaccine Displaying Respiratory Syncytial Virus Glycoprotein Induces Protective Immunity against RSV Infection without Vaccine-Enhanced Disease
Q55383943CRISPR therapeutic tools for complex genetic disorders and cancer (Review).
Q37980587Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks
Q40039573Combination of baculovirus-expressed BMP-2 and rotating-shaft bioreactor culture synergistically enhances cartilage formation
Q59358457Construction of a highly efficient display system for baculovirus and its application on multigene co-display
Q57001380Display of Porcine Epidemic Diarrhea Virus Spike Protein on Baculovirus to Improve Immunogenicity and Protective Efficacy
Q40055149Display of heterologous proteins on gp64null baculovirus virions and enhanced budding mediated by a vesicular stomatitis virus G-stem construct
Q30427591Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses
Q42062273Gene expression profiles in primary duodenal chick cells following transfection with avian influenza virus H5 DNA plasmid encapsulated in silver nanoparticles
Q39665121Hemagglutinin Displayed Baculovirus Protects Against Highly Pathogenic Influenza
Q39875287Hybrid of baculovirus and galactosylated PEI for efficient gene carrier
Q43434704Immune responses to baculovirus-displayed enterovirus 71 VP1 antigen
Q33490614Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses
Q37729202Induction of antitumor immunity against mouse carcinoma by baculovirus-infected dendritic cells
Q37547066Innate immune response induced by baculovirus attenuates transgene expression in mammalian cells
Q37909427Insect cell technology is a versatile and robust vaccine manufacturing platform
Q39825058Localization of VP28 on the baculovirus envelope and its immunogenicity against white spot syndrome virus in Penaeus monodon
Q92223350Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances
Q34070469Oral vaccination of baculovirus-expressed VP28 displays enhanced protection against White Spot Syndrome Virus in Penaeus monodon
Q30390108Particle and subunit-based hemagglutinin vaccines provide protective efficacy against H1N1 influenza in pigs
Q39830488Production of scFv-displaying BmNPV in silkworm larvae and its efficient purification
Q30374662Pseudotype-based neutralization assays for influenza: a systematic analysis.
Q30373913Safety and immunogenicity of H5N1 influenza vaccine based on baculovirus surface display system of Bombyx mori
Q30382226Strategies towards universal pandemic influenza vaccines.
Q36235817Two Distinctive Phenotypes of AcMNPV Display Different Immune Abilities and Intracellular Destiny
Q38243160Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens
Q33396583WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine